Skip to content
‹ Back to IndustriesHealthcare

USP CLASS VI CERTIFICATION

The complexities of medical device bio-compatibility can be difficult to navigate. In this post, we will explain how plastics are classified and tested to ensure patient safety. The U.S. Pharmacopeial Convention (USP) is a nonprofit organization responsible for creating standards for a variety of healthcare elements, including devices and equipment. The USP promotes bio-compatibility for…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

·
Share

Free workspace

Turn your Healthcare expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

The complexities of medical device bio-compatibility can be difficult to navigate. In this post, we will explain how plastics are classified and tested to ensure patient safety.

The U.S. Pharmacopeial Convention (USP) is a nonprofit organization responsible for creating standards for a variety of healthcare elements, including devices and equipment. The USP promotes bio-compatibility for plastics and polymers that come in contact with patient tissue. For these materials, there are six classes, with VI being the most stringent. While the first five classifications are valuable for certain materials, Class VI is the most compatible for medical applications.

USP Class VI – Three Evaluations to Ensure Safety

For the USP Class VI, there are three tests that materials must meet to be deemed safe. There are four standards that these evaluations test: purity, strength, quality and consistency. Here are the three tests explained:

  • Acute Systemic Toxicity measures the toxicity and irritation when a sample of the material is administered orally, placed on the skin or inhaled. It is extracted in up to four solutions: saline, vegetable oil, alcohol saline and polyethylene glycol. The test model is then observed for three days to determine any ill effects.
  • Intracutaneous determines the material’s toxicity and localized irritation when it touches live skin. It is extracted using the same four solutions. Test and control sites are compared to see if there is any significant reaction.
  • Implantation assesses toxicity, infection and irritation of intramuscular These implantations are observed for five to seven days to determine if there is any negative response.

These tests focus on toxicity while evaluating temperature over specific time periods. If a material does meet rigorous USP Class VI standards, then it is likely to be accepted by the FDA and USDA. Class VI testing encompasses any kind of possible applications that include the standard polar and nonpolar extracts required for ISO 10993-12 for completed devices. It’s considered the gold standard for medical-grade raw materials.

The USP Class testing was initially intended for polymers but can also be used to test other materials that encounter patients. The Class labels are meant to represent real-world usage.

EVA from Presco Meets Class VI

EVA (ethylene-vinyl acetate), is a copolymer consisting of ethylene and vinyl acetate. This medical grade film is a soft, clear material that can be RF-welded to create medical solution containers and tubing sets.

With rising concerns regarding the use of PVC in medical applications, EVA has been found to be a suitable alternative for medical use. In fact, for medical bags, EVA is the preferred choice—it has proven track record spanning three decades of wide use in medical device applications, particularly in IV therapy.

Why Choose EVA?

  • 30% lighter than PVC for a better yield and lower shipping costs
  • EVA has better tear and burst strength
  • Exceptional sealing properties
  • Strong impact resistance and cold crack properties
  • Meets all regulatory requirements of the market
  • Bio-compatible as certified with USP Class VI testing
  • No plasticizers or chlorine
  • Printable for fill lines

Pres-Flex EVA is Presco’s first PVC-free manufacturing capability for engineered film. To learn more about USP Class VI certified EVA film from Presco, contact us today. Our team of experienced professionals can guide you through your organization’s unique needs to determine whether this highly-favored PVC alternative is appropriate for your manufacturing processes.

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Book DemoSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Healthcare Insights

TotalCare's monthly mock codes paid off in a real code blue

TotalCare's monthly mock codes paid off in a real code blue

TotalCare runs a monthly mock code at each of its freestanding Metroplex emergency rooms, trains BLS, ACLS and PALS in house at no cost to staff, and plans to seek ANCC accreditation so its classes count toward the 20 contact hours Texas requires of nurses. Its ER clinical director credits the drills for a recent code blue the team ran flawlessly.

  • 01Every TotalCare emergency room in the Metroplex now runs a mock code every month, and a physician credited the drills in a text after a recent real code blue.
  • 02ANCC accreditation, which TotalCare is pursuing so its classes can offer contact hours Texas accepts for license renewal, carries a $4,950 first-time application fee effective January 1, 2026, and requires at least six months of compliance before applying.
  • 03A study in an American Heart Association journal found that top hospitals for cardiac arrest survival practiced on a fixed schedule and had responsive leadership, and that the near-universal availability of BLS and ACLS training is unlikely to be sufficient on its own.

Oct 19, 2026

Why young children die from local anesthetic overdoses in dental offices

Why young children die from local anesthetic overdoses in dental offices

Dentist anesthesiologists Stanley Malamed and Jason Brady told HealthFirst's Health First Talks podcast that fatal local anesthetic overdoses in young dental patients follow a chain of small errors: one-visit treatment plans, plain 3% mepivacaine, four quadrants injected at once and adult cartridges. Oral Health Group estimates LAST at 0.27 cases per 1,000 administrations. Brady caps his anesthetic tray at 90% of the maximum recommended dose.

  • 01Plain 3% mepivacaine is a sound one-quadrant drug for a child; beyond one quadrant, Malamed says epinephrine must be in the cartridge because it holds the drug in the nerve and keeps blood levels down.
  • 02Oral Health Group estimates LAST at about 0.27 cases per 1,000 local anesthetic administrations and reports cardiac signs come before any nervous system warning in about 20% of atypical cases.
  • 03Brady preps a tray holding 90% of the patient's calculated maximum recommended dose so a distracted operator cannot reach past it mid-case.

Oct 16, 2026

Suki raises $90M to take its AI scribe beyond note-taking

Suki raises $90M to take its AI scribe beyond note-taking

The funding backs a bet that scribes become clinicians' main AI interface, which changes how health systems evaluate them.

  • 01An ambient scribe already holds the patient context from the visit, and in early testing that context drove clinicians to prefer context-aware UpToDate answers 83% of the time.
  • 02Once a scribe starts answering clinical questions, note accuracy stops being enough to judge it. Regenstrief and Suki are building a framework that could add standardized metrics for answers too.

Oct 15, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512